BioCentury | Oct 18, 2017
Translation in Brief

Neutrophil bias

...also prevent development in stroke, he said. In contrast, stroke trials for the iron chelator deferoxamine...
BioCentury | Jan 27, 2017
Targets & Mechanisms

Death metal

...nutrient-starved cancer cells, likely by increasing intracellular iron levels. Suppressors (red) include the iron chelator deferoxamine...
BioCentury | May 9, 2016
Clinical News

Ferriprox deferiprone regulatory update

...patients with thalassemia. The agency recommends approval of Ferriprox, which is indicated for use when deferoxamine...
BioCentury | Jan 22, 2015
Distillery Techniques

Techniques: Polymer matrix transdermal drug delivery system

...human skin samples and normal mice, topically administered polymeric micelles encapsulating the generic iron chelator deferoxamine...
...In a mouse model of pressure-induced diabetic ulcers, a transdermal patch loaded with the micelle-encapsulated deferoxamine...
BioCentury | May 13, 2013
Clinical News

Exjade deferasirox regulatory update

...contained methodological weaknesses and did not show that Exjade is at least as effective as deferoxamine...
...>=6 years with beta thalassemia major who receive frequent blood transfusions and second-line treatment, when deferoxamine...
BioCentury | Jan 7, 2013
Clinical News

Exjade deferasirox regulatory update

...a label expansion for Exjade deferasirox to treat chronic iron overload requiring chelation therapy when deferoxamine...
BioCentury | Dec 3, 2012
Clinical News

Exjade deferasirox regulatory update

...label of Exjade deferasirox to include treatment of chronic iron overload requiring chelation therapy when deferoxamine...
BioCentury | Oct 17, 2011
Clinical News

Ferriprox deferiprone regulatory update

...60 countries to treat iron overload associated with thalassemia major when the standard therapy of deferoxamine...
BioCentury | Sep 19, 2011
Clinical News

Ferriprox deferiprone regulatory update

...61 countries to treat iron overload associated with thalassemia major when the standard therapy of deferoxamine...
BioCentury | Sep 15, 2011
Company News

FDA panel backs Apotex's Ferriprox

...61 countries to treat iron overload associated with thalassemia major when the standard therapy of deferoxamine...
Items per page:
1 - 10 of 23